CRVS

Corvus Pharmaceuticals, Inc.#2 · 2024HTFC

Yearly return

+204%

Peak return

+468%

Max drawdown

-62%

ADR (20 days)

+8.9%

Base

22 days / -33.7%

Prior run

+265%

Breakout volume

4.3x

Pivot

$5.22

Healthcare · Healthcare & Biotech

Continue in the full Atlas

Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare CRVS with the current market directly.